CASP3 and hepatocellular carcinoma: LncRNA PDPK2P promotes AKT phosphorylation and inhibits the expression of caspase-3 by interacting with PDK1, and then inhibits the apoptotic pathway of hepatocellular carcinoma cells and promotes proliferation of tumor cells (38).